Concord Drugs Limited (BOM:538965)
India · Delayed Price · Currency is INR 68.40
-3.29 (-4.59%)
At close: Oct 16, 2026
Concord Drugs Market Cap
Concord Drugs has a market cap or net worth of 901.17 million as of October 16, 2026. It is the 41,568th most valuable company in the world and the 3,390th biggest in India. Its market cap has increased by 38.64% in one year.
Market Cap
901.17M
Enterprise Value
1.04B
Revenue
860.69M
Global Rank
Country Rank
#3,390 India
PE Ratio
39.78
ChartMarket Cap Chart
Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 901.17M, an increase of 522.34%. That is a compound annual growth rate of 16.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 901.17M | -17.07% |
| Dec 31, 2025 | 1.09B | 188.24% |
| Dec 31, 2024 | 377.00M | -36.87% |
| Dec 29, 2023 | 597.20M | 109.83% |
| Dec 30, 2022 | 284.61M | 1.24% |
| Dec 31, 2021 | 281.11M | 40.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Parnax Lab | 1.27B |
| Aayush Wellness | 1.21B |
| Makers Laboratories | 1.21B |
| Asston Pharmaceuticals | 1.12B |
| Pharmaids Pharmaceuticals | 1.07B |
| Parmax Pharma | 947.57M |
| Mercury Laboratories | 912.00M |
| Denis Chem Lab | 863.41M |